Lies of the United Nation and Cannabis

Plant or Pills

On March 25, 1972, the Final Act to the Single Convention on Narcotic Drugs, 1961, as Amended by the 1972 Protocol Amendment, was signed.  Although not self-executing, the provisions of the Single Convention must be incorporated into the domestic law by legislative acts in the signing party's country. 


The Preamble to this International treaty, states the aim, purpose and justification for the Convention:

"PREAMBLE

The Parties,

Concerned with the health and welfare of mankind, 

Recognizing that the medical use of narcotic drugs continues to be indispensable for the relief of pain and suffering and that adequate provision must be made to ensure the availability of narcotic drugs for such purposes, 

Recognizing that addiction to narcotic drugs constitutes a serious evil for the individual and is fraught with social and economic danger to mankind, 

Conscious of their duty to prevent and combat this evil,

Considering that effective measures against the abuse of narcotic drugs require co-ordinated and universal action, 

Understanding that such universal action calls for international co-operation guided by the same principles and aimed at common objectives, 

Acknowledging the competence of the United Nations in the field of narcotics control and desirous that the international organs concerned should be within the framework of that Organization, 

Desiring to conclude a generally acceptable international convention replacing existing treaties on narcotic drugs, limiting such drugs to medical and scientific use, and providing for continuous international co-operation and control for the achievement of such aims and objectives, 

Hereby agree" ...  to Articles 1 - 50 and the four schedules appended, all of which comprise the International Treaty on Drug Control.

Article 1 provides for Definitions applicable and used throughout the Convention;

Article 2 describes the Substances Under Control and within each schedule and the method of control applicable. 

  Schedule 1 includes cannabis and is subject to all measures of control      applicable to drugs under the Convention. 

  Schedule IV drugs, also included in Schedule 1, subject to all measures of  control "including adopting special measures of control which are  necessary having regard to the particularly dangerous properties of  those drugs ..."

Article 28 - CONTROL OF CANNABIS

1. If a Party permits the cultivation of the cannabis plant for the production of cannabis or cannabis resin, it shall apply thereto the system of controls as provided in article 23 (licensing requirements) respecting the control of the opium poppy. 

2. This Convention shall not apply to the cultivation of the cannabis plant exclusively for industrial purposes (fibre and seed) or horticultural purposes. 

3. The Parties shall adopt such measures as may be necessary to prevent the misuse of, and illicit traffic in, the leaves of the cannabis plant.

Article 33 - POSSESSION OF DRUGS 

The Parties shall not permit the possession of drugs except under legal authority.

Article 35 - ACTION AGAINST THE ILLICIT TRAFFIC 

  Having due regard to their constitutional, legal and administrative systems, ...

Article 36 -  PENAL PROVISIONS

1. Subject to its constitutional limitations, ... cultivation, production, manufacture, extraction, preparation, possession, offering, offering for sale, distribution, purchase, sale, delivery, brokerage, dispatch, transport, importation and exportation ... shall be punishable offences ... and that serious offences shall be liable to adequate punishment particularly by imprisonment or other penalties of deprivation of liberty

2. ...as an alternative to conviction or in addition to, the Parties may provide treatment, education, aftercare, rehabilitation and social integration ..

Compare the above to the following:

In reviewing the minutes to a 1971 United Nation 'symposium' discussing the research surrounding the chemistry and biological activity of cannabis, the following was noted:

Cannabis research at the Division of Narcotic Drugs, United Nations, Geneva is mandated with the primary function of internationally coordinating cannabis research in order to avoid unnecessary duplication of effort.

The emphasis of this international research was "to elucidate the effects of the compounds responsible for the psychoactive effects of cannabis in man, to quantify the constituents or their metabolites in biological fluids, to determine their toxicity and side effects and to correlate these data with the social effects of the drug."

Respecting the large number of new and unpublished data surrounding the positive findings from researching cannabis: 

The Symposium revealed that a large amount of knowledge had been accumulated on the chemistry of cannabis and the synthesis of the cannabinoids and their metabolites. The report stated that there still remains some uncertainty as to how much THC is absorbed by smoking, to give the biological high. It concluded that THC and cannabis of known potency can be used with confidence in large scale clinical trials. It was determined that within the next few years (by 1975 ?), the clinical data will shed new light on the two basic questions of the UN "How dangerous is cannabis?" and "What should we do about it?"

In summary, this is evidence that the United Nations vilified cannabis without any corroborating scientific evidence as to its dangers!

How can a plant go from a useful industrial and medicinal benefit to society, to a fate of condemnation needing international control under the suspicious auspices of protecting our health? 

Happy Liver - How YOU can Improve your Liver's Function

 getBook.at/Happy-Liver

Liver disease is a world wide problem and it is estimated that one in ten people have developed some form of liver disease. Unfortunately in western medicine, liver disease is commonly misdiagnosed until the disease is in an advanced stage. At this point, conventional western medicine will often prescribe chemically laden pills that mostly exasperate the problem. In addition, a large variance exists between conventional chemically laden pharmaceutical pills and that of natural plant based whole medicine.

Our liver is an amazing essential organ as it is able to regenerate itself, even when functioning at only 25%. One of its main roles in our bodies is detoxification. Unfortunately the amount of toxins in our everyday life impairs our liver's ability to optimally function.

The above  book describes the importance of our liver for vitality, energy and beauty, not to mention our overall health.  The above book - Happy Liver by Ryder Management Inc also introduces the reader to a number of existing natural remedies that can help remove the toxins in your liver and blood. 

It is imperative to understand how toxic our world is and the importance of assisting our liver with its detoxification function. This book includes a number of remedies, recipes and hints to help your liver to function at its best in order for you to regain your health, beauty and vitality.

Duplicity of Health Canada, FDA and WHO

Although Canada is in the process of passing the new Cannabis Act legislation on July 1, 2018, the Access to Cannabis for Medical Purposes Regulations (ACMPR) - annexed to Canada's 'Controlled Drugs and Substances Act, came into effect on August 5, 2016 and is expected to remain in effect for the first five years the new Cannabis Act is effective.

Despite the undeniable scientific research, evidence and randomized controlled trials, not to mention the abundance of analytical evidence (scientific evidence accumulated by observation, analysis and recording), Health Canada has published specific information for Health Care Practitioners regarding dosing, as follows:

Cannabis (marijuana, marihuana) is not an approved therapeutic drug in Canada. At present, while pointing to some potential therapeutic benefits, the scientific evidence does not establish the safety and efficacy of cannabis, to the extent required by the Food and Drug Regulations for marketed drugs in Canada, unless a particular cannabis product has received a notice of compliance from Health Canada and a Drug Identification Number (DIN) (e.g. nabiximols/Sativex®). However, the Access to Cannabis for Medical Purposes Regulations provide a mechanism for patients to access cannabis for medical purposes with the support of their physician or nurse practitioner (where authorized by provincial regulatory authorities).

The duplicity in the above opening paragraph to health care practitioners is obvious when compared with the number of drugs that the FDA and Health Canada approved and then revoked due to the original accepted fatal dose exceeding the standard. Vanessa's law is an example of how the FDA and Health Canada failed the people while pleasing Big Pharma.

How is it that Health Canada, mandated to protect the health of Canadians, be allowed to form laws, such as the ACMPR - stating that not enough scientific evidence exists on the safety and efficacy of this plant, while allowing a corporate giant such as Monsanto and its subsidiaries, affiliates and related corporations, to introduce genetically modified organisms into our food system, environment and everyday life, with scientific evidence revealing the harm these modified, unnatural products cause???

The United Nations appointed World Health Organization (WHO) is obviously benefiting from the duplicity in the GMO scam as evidenced by issuing the following statement about GMO food on their website:

8. Are GM foods safe?

Different GM organisms include different genes inserted in different ways. This means that individual GM foods and their safety should be assessed on a case-by-case basis and that it is not possible to make general statements on the safety of all GM foods.
GM foods currently available on the international market have passed safety assessments and are not likely to present risks for human health. In addition, no effects on human health have been shown as a result of the consumption of such foods by the general population in the countries where they have been approved. Continuous application of safety assessments based on the Codex Alimentarius principles and, where appropriate, adequate post market monitoring, should form the basis for ensuring the safety of GM foods.

Until Health Canada enacted the CESA (Canada Environment Safety Act), a number of Monsanto engineered "nano-products" have been grandfathered into use in Canada. Are these pre-CESA products safe?  The answer is, not enough scientific evidence is available.

The emerging FinTech (Financial Technology) Industry has the traditional banking industry shaking in their boots over fears of reduced profits. The Big Banks' Big Auditors' have all issued publications regarding "Banking Disruptive" and the threat of the emerging FinTech market's effect on the Big Banks' bottom line.

Canada's Big Six banks earned a combined net income of CA$34.9 BILLION in 2015 and it is these outrageous profits that provide a very attractive incentive for players outside the traditional banking system.

A 2014 publication by Deloitte entitled "Banking Disruptive"   states the following:

"Bank employees have historically been heavily incentivised to ensure customers opening current accounts are cross-sold credit cards and other loans and, in turn, insurance policies linked to these loans. Convenience and customers' lack of financial sophistication enabled banks to make high margins on these adjacent products."

Although all the major banks state their mission and objective is earning their customers trust and state that they act in the best interest of their customers, these same banks are profit oriented entities - and that, in itself, has an inherent primary focus of only having their shareholders' interests as priority.

As previously stated by a Big Auditing firm, the banking industry has relied on customers lack of financial knowledge to generate outrageous profits for them. Tellers, supervisors and their managers are each required to meet excessive marketing goals or risk being demoted or fired. In a story that broke on CBC News in March of this year, employees at the major big banks in Canada spoke out about the pressure to dupe customers in order to meet their unrealistic sales goals. These high pressured sales tactics are known as the 'hard sale' and involves applying pressure through forceful language or appealing to one's fears, emotions or greed in order to make a quick sale.

Canada's Big Banks were previously under fire in 2013 for replacing I/T or tech employees with temporary foreign workers. The CEO's at these banks vehemently denied such practices despite its continued use beginning in 2008.

Since the eighties and nineties, banks have been allowed to expand into the insurance and mutual fund markets. These new opportunities have allowed the Big Banks to manufacture and sell their own mutual fund products.  Branch staff have been educated in which of their bank's funds they are required to promote and sell at any given time. As sure as they charge fees, the mutual funds promoted to you, complete with their hidden fees and commissions, benefit their bank shareholders more than you.

With respect to mortgage lending, unless you negotiate your interest rate, term and total amortization period, these banks will sell you the highest rate and longest term and amortization period which is NOT in your best interest, but benefits their shareholders handsomely. Shopping around for your mortgage, including playing one bank against another, will ensure you receive the lowest rate and terms.

Another banking practice that is criminal in its form but is a cash cow to the big bank is insisting that you need and selling you their 'credit protection insurance'. This type of insurance, in most cases, is known to be  post claim underwriting (this means that your eligibility for coverage is not determined until a claim is filed and, at this stage, the claim is usually denied for a number of undisclosed reasons). Any type of credit protection insurance sold by banks provide them with a huge windfall to their bottom line and only allows you the privilege of paying their monthly premium.

Although the FinTech emerging market is an imminent and potential threat to the Big Banks monopoly on customers unquestionable historical blind trust, an alternative to banking with for-profit organizations is banking with a credit union. In this relationship, customers buy shares and are considered "owners" who also share in a percentage of year-end profits. Customers at credit unions are not pressured into unneeded and unwanted products AND honesty about their products relative to customers needs, are communicated and disclosed.

Future articles will provide more details on each of the topics described above.

Dismantle the United Nations and the World Health Organization

Research shows that after WWII, the Rockefellers needed to create the ideal political framework if their monopolies over oil and the drug/medicine business were to survive. With the assistance of the Rockefeller influence, in 1945, the United Nations was founded in San Francisco. In addition, founded as organizations that purportedly were created to serve the well-being of the people, the UN created subsidiary organizations including the World Health Organization (WHO) and the World Trade Organization (WTO), which soon turned out to be nothing more than the political arms of the global oil and drug interests.

 In 1963, under the pretense of protecting the health of consumers, the United Nations was instrumental in launching a four decade battle to outlaw natural health products, including vitamins and other non-patentable approaches to health. The ultimate goal, was to eliminate all competition for the soon to be multi-billion dollar drug enterprise. This (criminal) global strategy monopolized the health for billions of people, by providing lethal pills while depriving access to lifesaving information about the health benefits of natural products. 

Between 1990-1992, Dr. Rath identified micronutrient deficiency as a primary cause for most diseases, including heart attacks, high blood pressure, diabetic circulatory problems, cancer and autoimmune disorders said to be caused from an unknown source with no known cures. 

The World Health Organization (WHO) was established in 1948 as a specialized agency of the UN to serve as the authority for directing and coordinating international health matters and public health in general It is said that WHO fulfills these responsibilities through its extensive programme of publications.  That's all it has to do? Support Big Pharma research that further supports its goal of monopolization? 

Consider the latest 2016 publication sponsored by WHO and written by the Department of Mental Health and Substance Abuse entitled "The health and social effects of non medical cannabis use" .This publication is lacking in reporting current information as it reports that the long-term health effects of cannabis use includes mental disorders including psychoses, depression, anxiety and suicide behavior; cardiovascular disease; chronic obstructive pulmonary disease, respiratory disease and cancer. Ironically, a number of patent applications have been filed using cannabis to treat the above disorders. 

This publication also reports the harmful effects of cannabis-use disorder.  Cannabis use disorder is defined in the fifth revision of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5)   as the "continued use of cannabis despite clinically significant impairment, ranging from mild to severe." It is reported that no medication has been proven effective in treating cannabis use disorder, however, most recently, the synthetic version of THC, known as Dronabinol, has been considered as an effective medication for cannabis use disorder. As an aside, controlled studies on Dronabinol use has been shown to create the negative effects reported as being associated with the use of the whole plant. 

Antipsychotic drugs produced by Big-Pharma, are prescribed to children at alarming rates, without studying the long-term effects, despite FDA black box warnings. Most antipsychotic medication use among children and adolescents is “off label”, that is, for indications that are not approved by the FDA or used for children who are younger than the approved age ranges.

Conversely, cannabis is considered a controlled substance under Schedule I of the CSA in the US - where it is considered 'to have a high potential for abuse, no currently accepted medical use in treatment and a lack of accepted safety standards for using the drug or other substance under medical supervision.'

The WHO's most recent study (noted above) and its emphasis on "cannabis use disorder" is contrary to fundamental justice including the principles of "overbreadth" and "arbitrary" with respect to rejecting herbal medicine in favor of  harmful pharmaceutical pills.  

The WHO, in pursuing their objective of "shaping the research agenda and stimulating the translation and dissemination of valuable knowledge" is overbroad in supporting harmful pharmaceutical pills while vilifying cannabis consumption with incorrect and faulty information to the public at large.

Cannabinoid patents

Although the cannabinoids THC and CBD are the only two cannabinoids required to be disclosed by the Licensed Producers under Canada's marijuana legislation, some dispensaries in the US also only disclose these two cannabinoids in their strains, choosing to ignore the following cannabinoids that have a greater presence over CBD in Indica strains: 


Cannabigerol (CBG) - the link for this cannabinoid is for a patent application filed by GW Pharmaceuticals in treating depression and other mood disorders. 

CBG for a number of diseases - the diseases or conditions to be treated are taken from the group: pain, neurodegenerative disease, ischemic disease, brain injury or damage, acquired brain injury, age related inflammatory or autoimmune disease, cachexia, nausea and vomiting, glaucoma, movement disorders, rheumatoid arthritis, asthma, allergy, psoriasis, Crohn's disease, systemic lupus erythematosus, diabetes, cancer, osteoporosis, renal ischemia and nephritis.  This was filed by GW Pharma

Cannabichromene (CBC) - GW Pharma claims to have invented a method for extracting this cannabinoid

CBC and Terpenes  - GW's invention in this patent is in the treatment of cancer  where the use of at least 50% of the phytocannabinoid component is not THC or CBD but CBC and with at least 15% of the non-phytocannabinoid containing component comprising certain terpenes such as myrcene and pinene. 

CBC as an antiinflammatory and antimicrobial  - filed by the University of Mississippi

Tetrahydrocannabivarin (THCV) -  by GW Pharma - using THCV for the treatment of obesity, schizophrenia, epilepsy, Alzheimer's, bone disorders, bulimia or the treatment of drug, alcohol or nicotine abuse or dependency

THCV, CBG, CBC and/or CBDV for intestinal inflammatory diseases -  this patent application filed by GW Pharma is for any one of the named cannabinoids for the preferential treatment of either ulcerative colitis or Crohn's disease


The above patents are just a drop in the bucket relative to the number of studies conducted and patent applications filed using cannabis's medicinal properties.